Discover 1,171 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,171
Sinus Disease in Young Children With Cystic Fibrosis
for
Cystic Fibrosis in Children, Cystic Fibrosis,
Location: Cincinnati OH, Charlottesville VA, Iowa City IA,
Sponsor: University of California, Los Angeles
Sex: All
Age: 2 - 8
Code: NCT06191640
Recruiting
Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
for
Growth Hormone Deficiency
Location: Cincinnati OH, Morristown NJ, Kansas City MO,
Sponsor: Altus Pharmaceuticals
Sex: All
Age: 3 - 13
Code: NCT00837863
Phase2, Recruiting
Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
for
Trichomonas Vaginalis
Location: Cincinnati OH
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: Female
Age: 14 - 35
Code: NCT00706368
Recruiting
Registry for Stage 2 Type 1 Diabetes
for
Type 1 Diabetes
Location: Cincinnati OH, Columbus OH, Indianapolis IN,
Sponsor: Sanofi
Sex: All
Age: 0+
Code: NCT06481904
Recruiting
International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
for
Diffuse Intrinsic Pontine Glioma,
Location: Cincinnati OH
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0+
Code: NCT03101813
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 0
Code: NCT00006132
Phase3, Recruiting
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age
for
Prevention of Pneumonic Plague Resulting From Aerosol Exposure to Yersinia Pestis,
Location: Cincinnati OH
Sponsor: Dynavax Technologies Corporation
Sex: All
Age: 18 - 55
Code: NCT07207408
Phase2, Not recruiting
Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa
for
Hidradenitis Suppurativa
Location: Cincinnati OH, Worcester MA, Redwood City CA
Sponsor: Phoenicis Therapeutics
Sex: All
Age: 18+
Code: NCT05020730
Phase2, Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
for
Plasma Cell Myeloma Refractory
Location: Cincinnati OH, Canton OH, Dearborn MI, Royal Oak MI,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06356571
Phase2, Recruiting
Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
for
Angioedema
Location: Cincinnati OH
Sponsor: Bernstein, Jonathan A., M.D.
Sex: All
Age: 18+
Code: NCT01036659
Phase2, Recruiting
Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
for
Rhinitis
Location: Cincinnati OH
Sponsor: Bernstein, Jonathan A., M.D.
Sex: All
Age: 18 - 65
Code: NCT00406094
Recruiting
CAMPUS Expanded "Classification and Assessment of Mental Health Performance Using Semantics Expanded"
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
for
Major Depressive Disorder
Location: Dayton OH, St. Louis MO, Alpharetta GA, Memphis TN,
Sponsor: Neuralstem Inc.
Sex: All
Age: 18 - 61
Code: NCT02724735
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Dayton OH, Indianapolis IN, Ann Arbor MI, Warren MI,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Dayton OH, Springboro OH, Columbus OH, New Albany IN,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT07184931
Phase3, Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis